If you’re thinking about building an exosome serum into your Skin Games case study this season, the short answer is that nothing about the trend disqualifies you, but nothing about the trend scores for you either. TSG judges score your reasoning, so the product only helps if you can explain why it belongs in this client’s plan, and the legal and scientific picture around exosomes makes that explanation harder than it is for a retinoid or a peptide. If you haven’t read it yet, start with Everything You Need to Know About The Skin Games 2026-27 Season, because the rules we get into below sit inside that season’s format.
Why exosomes are suddenly in every treatment room
Exosomes are tiny vesicles, roughly 30 to 150 nanometers across, that cells release to carry proteins, lipids, and small RNAs to other cells, and the reason the skincare world got excited is that lab work, in cell cultures and animal models, shows stem-cell-derived exosomes can influence how fibroblasts behave and how fast a wound closes. That’s real science, and it’s the reason you’re seeing them marketed as the next step after peptides, especially when they’re paired with microneedling or laser.
But there are two different things hiding under that one word, and you want to make sure you separate them. There’s the laboratory biology, which is genuine, and there’s the product on the shelf, where the source might be plant material, salmon, human stem cells, or milk, and where “contains exosomes” can mean anything from a purified preparation to a plant extract with a new name on the bottle. The first one earns your interest, and the second one is the thing you actually have to defend.
The legal part nobody wants to read
This is where it gets complicated, and it’s worth slowing down on because it’s the part that can cost you more than a point deduction. On December 6, 2019, the FDA issued a public safety notification about exosome products after, in its words, “multiple recent reports of serious adverse events experienced by patients in Nebraska who were treated with unapproved products marketed as containing exosomes.” The same notice states that exosomes used to treat diseases and conditions in humans are regulated as drugs and biological products, and that “there are currently no FDA-approved exosome products.”
Now, that doesn’t mean every topical bottle is illegal, and I don’t want you walking away thinking so. What it means is that the wording matters more than most people realize, because a cosmetic can say it improves how skin looks and a drug-style claim like “regenerates” or “stimulates collagen” starts to read like a biological effect, and that’s exactly the kind of claim regulators care about. Several law and trade sources that cover aesthetic practice make this same distinction, so if a brand’s marketing leans on regenerative language, ask yourself whether you’re comfortable repeating it in a document that real judges, and eventually the public, will read.
TSG’s own rules already point in the same direction. Competitors can’t represent a product or treatment as diagnosing, treating, curing, or preventing disease beyond what’s lawful in their scope.
What the evidence actually supports
Here’s the honest version, and it’s more encouraging than the hype-skeptics make it sound and less exciting than the brands do. A 2026 systematic review covering 19 human studies reported associations with better hydration, elasticity, wrinkles, pores, and pigmentation in the short term, but most of those studies weren’t randomized, the methods varied a lot, and follow-up was short, so the reviewers called the evidence early and not yet confirmed. Other summaries of the field note that trials tend to be small and often manufacturer-sponsored, and that the strongest signal so far is for topical use after a procedure, such as faster resolution of redness, rather than for a serum applied to an intact barrier.
That’s the pattern to hold onto, because it tells you where an exosome product is easiest to justify and where it isn’t. A calming, post-procedure application with a documented reason is a defensible choice, and a claim that an exosome serum beats well-studied actives like retinoids or vitamin C is something the published trials don’t currently support.
What TSG judges are actually scoring
I’ll say this plainly, because it’s the part of the title that matters: I couldn’t find a TSG judge on record about exosomes, so I’m not going to put words in anyone’s mouth. What I can show you is what the judges and the rules do say, and it applies to any trending ingredient you bring in.
The written case study asks you to list the top two or three performance ingredients and the impact they have on the skin, rather than leaning on a brand name, and to avoid lines like “same as last week” because every treatment is different. The scoring guide says the same thing from the judging side: competitors are rewarded when they can clearly explain why they made the choices they made, not just what they did. David Valenzuela of WISH Skin Health framed the whole standard as “one size fits one,” and Aggie Singh’s way of putting barrier-first thinking was “if your roof is leaking, you don’t start by replacing the carpets.”
Put those together and you can see how an exosome product would be judged, which is the way any new active is judged. If your client’s barrier is compromised and you reach for a regenerative serum before you’ve repaired the roof, the trend is working against you. If the client has just had a procedure and you can explain why a calming, supportive product fits that window, the reasoning is doing the scoring and the ingredient is just along for the ride.
How to document it if you use one
You want to make sure you can answer four things on paper before the product ever goes on a model. What is the actual source and form of the exosome ingredient, and does the label say so clearly. What specific effect on the skin are you expecting, described in functional terms rather than miracle terms. Why is this right for this client at this point in the eight weeks, given their barrier and their goals. And what would make you stop using it if it didn’t go well.
Also keep the scope rules in view, because the trend is often paired with other services. TSG’s rules reserve injectables, medical microneedling beyond 0.5mm including PRP and PRF, energy-based devices, deeper peels, and prescription topicals for the Open Medical category with a licensed medical professional, and using them elsewhere carries an automatic five-point deduction. An exosome serum that’s only meaningful because it’s being worked in with one of those procedures is a plan that may have a scope problem before it has a results problem.
So that’s the whole idea, broken down as simply as possible: the exosome wave is real enough to be worth understanding and young enough that the law and the evidence are still moving, which means the competitor who wins with it will be the one who explains it best, not the one who uses it first. And if you want the full picture of how judges across every category read your reasoning, A Season-by-Season Scoring Guide on What TSG Judges Are Really Looking For is where to go next.
Everything about this season’s categories, ticket tiers, and entry paths lives in the season guide, so that’s the best next click if you’re still deciding how you want to compete.